Biocon launches pre-filled safety syringe
Biocon Limited, the country's leading biotechnology company, today announced the launch of a new drug delivery system, a pre-filled safety syringe device for two of its lifesaving drugs for kidney and cancer patients.
By PTI |
BANGALORE: Biocon Limited, the country's leading biotechnology company, today announced the launch of a new drug delivery system, a pre-filled safety syringe device for two of its lifesaving drugs for kidney and cancer patients.
The new device, launced in collaboration with US-based Safety Syringes Inc, would reduce the chances of needle stick injuries, Biocon CMD Kiran Mazumdar Shaw told reporters.
The products named `Erypro Safe' and `Nufil Safe' have a needle guard that is activated immediately after injecting the patient, thus reducing the chances of needle stick injuries, which often exposes health workers and doctors to chances of picking up of blood borne infections like HC, HB and HIV.
Though erythropoietin used in the treatment of kidney diseases and the granulocyte-colony stimulating factor (GCSF) used by cancer patients, were currently made available in pre-filled syringe form by other companies, this is the first time in India that Biocon has launched it in a syringe form incorporating the safety device needle feature, she said.
Currently Erypro Safe is available in vial form, but with the introduction of the drug in the pre-filled syringe form encapsulated in a safety device, the patient can now be injected the drug conveniently, without drawing the drug into a syringe from a vial and measuring it. The patient can purchase the syringe and directly inject it without exposing himself to needle stick injuries or others to it.
The syringe has improved needle sharpeness of five bevel size as against the three bevel size. The force required to penetrate a patient's skin due to this sharpenss is 25 per cent lesser, reducing the patient's perceived pain.
"Pre-filled syringes are advantageous for self-injecting patients. The needle is a retractable needle, and device is tamper proof and ensures that it is non reusable", she said.a
The products named `Erypro Safe' and `Nufil Safe' have a needle guard that is activated immediately after injecting the patient, thus reducing the chances of needle stick injuries, which often exposes health workers and doctors to chances of picking up of blood borne infections like HC, HB and HIV.
Though erythropoietin used in the treatment of kidney diseases and the granulocyte-colony stimulating factor (GCSF) used by cancer patients, were currently made available in pre-filled syringe form by other companies, this is the first time in India that Biocon has launched it in a syringe form incorporating the safety device needle feature, she said.
Currently Erypro Safe is available in vial form, but with the introduction of the drug in the pre-filled syringe form encapsulated in a safety device, the patient can now be injected the drug conveniently, without drawing the drug into a syringe from a vial and measuring it. The patient can purchase the syringe and directly inject it without exposing himself to needle stick injuries or others to it.
The syringe has improved needle sharpeness of five bevel size as against the three bevel size. The force required to penetrate a patient's skin due to this sharpenss is 25 per cent lesser, reducing the patient's perceived pain.
"Pre-filled syringes are advantageous for self-injecting patients. The needle is a retractable needle, and device is tamper proof and ensures that it is non reusable", she said.a
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
